03/29/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
The National Health Surveillance Agency (ANVISA) published on Wednesday (28/3) in the Official Gazette (DOU), the suspension of import of pharmaceutical ingredient Clindamycin Hydrochloride.
The manufacturer Zhejiang Candorly Pharmaceutical CO. LTD. does not meet the regulatory requirements of ANVISA.
Press / Anvisa
Source: ANVISA
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.